Bayer Cropscience enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast closeFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
1,4721,4729211,211902
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
Reference items — trailing FY values
5,6755,6755,4735,103—
874874690954—
780780605880—
1,0791,079—952—
1,0391,039—906—
1,0361,036—904—
39.939.9—45.7—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAYERCROP₹3,289.80

Bayer Cropscience Ltd.

· Chemicals
₹ CrorePeersUPLPIINDRALLISATULSHKANURASCAMLINFINECLEAN
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current
last close
- Cash, Equiv & ST Investments901.91,210.7920.91,472.01,472.0
Reference Items — Trailing FY Values
Sales—5,103.25,473.45,675.05,675.0
EBITDA—954.0689.6873.7873.7
EBIT—880.0604.7779.7779.7
Operating Cash Flow—951.6—1,078.51,078.5
Free Cash Flow—905.9—1,038.61,038.6
FCFF (free cash flow to the firm)—904.2—1,036.11,036.1
Capital Expenditure—45.7—39.939.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.